PUNE, India, January 27, 2017 /PRNewswire/ --
The global humanized mouse model market is projected to reach USD 116.0 million by 2021 from USD 73.3 million in 2016, growing at a CAGR of 9.6% in the next five years (2016 to 2021) propelled by increase in R&D activities carried out by pharmaceutical and biotechnology
Browse 69 tables and 47 figures, 12 Company profiles spread across 182 pages available at http://www.reportsnreports.com/reports/825124-humanized-mouse-model-market-by-type-genetic-cell-based-cd34-pbmc-blt-application-neuroscience-hematopoiesis-oncology-immunology-infectious-diseases-end-userpharmaceutical-biotech-companies-cro-st-to-2021.html .
Growing adoption of personalized medicine to fuel the demand for personalized mice models, continuous support in the form of investments and grants from the government and private sectors, and increase in R&D activities carried out by pharmaceutical and biotechnology companies are the key factors driving the growth of the market. However, regulations & laws formulated for ethical use of animals and increased use of rat models are restraining the growth of the market to a certain extent.
The global humanized mouse model market is segmented on the basis of type, application, end user, and region. In 2016, North America is expected to account for the largest share of the global humanized mouse model market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is projected to have the highest growth rate in the forecast period. The high growth rate of this segment can be attributed to factors such as increasing investments from the government and private sector in China, growing biomedical and medical research industry in Japan, growing presence of global players in India, and increasing pharmaceutical and biotech R&D activities in Korea.
Key players in the global humanized mouse model market include The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Harbour Antibodies BV (China), HuMurine Technologies, Inc. (U.S.), Vitalstar Biotechnology Co. Ltd. (China), Crown Bioscience, Inc. (U.S.), ingenious targeting laboratory (U.S.), Axenis S.A.S (France), TRANSGENIC, Inc. (Japan), genOway S.A. (France), and Horizon Discovery Group plc (U.K.). Order a copy of Humanized Mouse Model Market by Type (Genetic, Cell-based (CD34, PBMC, BLT)), Application (Neuroscience, Hematopoiesis, Oncology, Immunology & Infectious diseases) & End User(Pharmaceutical & Biotech Companies, CRO)) - Global Forecast to 2021 research report at http://www.reportsnreports.com/purchase.aspx?name=825124 .
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, collaborations, agreements, partnerships, alliances, grants, licensing, contracts, acquisitions, and expansions) to increase their market shares and establish a strong foothold in the global market.
Explore more reports on biotechnology market at http://www.reportsnreports.com/market-research/biotechnology/
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Contact: Ritesh Tiwari 2nd Floor, Metropole Building, Next to Inox Theatre, Bund Garden Road, Pune - 411013. Maharashtra, India. + 1 888 391 5441 firstname.lastname@example.org
Connect with Us: LinkedIn: http://www.linkedin.com/company/reportsnreports RSS/Feeds: http://http://www.reportsnreports.com/feed/l-latestreports.xml
Subscribe to our Free Newsletters!